177 related articles for article (PubMed ID: 15141018)
1. Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription.
Cho SD; Jiang C; Malewicz B; Dong Y; Young CY; Kang KS; Lee YS; Ip C; Lü J
Mol Cancer Ther; 2004 May; 3(5):605-11. PubMed ID: 15141018
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of action.
Husbeck B; Bhattacharyya RS; Feldman D; Knox SJ
Mol Cancer Ther; 2006 Aug; 5(8):2078-85. PubMed ID: 16928829
[TBL] [Abstract][Full Text] [Related]
3. Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells.
Jiang C; Wang Z; Ganther H; Lü J
Mol Cancer Ther; 2002 Oct; 1(12):1059-66. PubMed ID: 12481429
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of naturally occurring and synthetic organoselenium compounds on biomarkers in androgen responsive and androgen independent human prostate carcinoma cells.
Pinto JT; Sinha R; Papp K; Facompre ND; Desai D; El-Bayoumy K
Int J Cancer; 2007 Apr; 120(7):1410-7. PubMed ID: 17205524
[TBL] [Abstract][Full Text] [Related]
5. Differential involvement of reactive oxygen species in apoptosis induced by two classes of selenium compounds in human prostate cancer cells.
Li GX; Hu H; Jiang C; Schuster T; Lü J
Int J Cancer; 2007 May; 120(9):2034-43. PubMed ID: 17230520
[TBL] [Abstract][Full Text] [Related]
6. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
[TBL] [Abstract][Full Text] [Related]
7. Prostate specific antigen expression is down-regulated by selenium through disruption of androgen receptor signaling.
Dong Y; Lee SO; Zhang H; Marshall J; Gao AC; Ip C
Cancer Res; 2004 Jan; 64(1):19-22. PubMed ID: 14729601
[TBL] [Abstract][Full Text] [Related]
8. Sodium selenite inhibits interleukin-6-mediated androgen receptor activation in prostate cancer cells via upregulation of c-Jun.
Gazi MH; Gong A; Donkena KV; Young CY
Clin Chim Acta; 2007 May; 380(1-2):145-50. PubMed ID: 17346688
[TBL] [Abstract][Full Text] [Related]
9. PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells.
Hu H; Jiang C; Li G; Lü J
Carcinogenesis; 2005 Aug; 26(8):1374-81. PubMed ID: 15845651
[TBL] [Abstract][Full Text] [Related]
10. Monomethyl selenium--specific inhibition of MMP-2 and VEGF expression: implications for angiogenic switch regulation.
Jiang C; Ganther H; Lu J
Mol Carcinog; 2000 Dec; 29(4):236-50. PubMed ID: 11170262
[TBL] [Abstract][Full Text] [Related]
11. Induction of caspase-mediated apoptosis and cell-cycle G1 arrest by selenium metabolite methylselenol.
Wang Z; Jiang C; Lü J
Mol Carcinog; 2002 Jul; 34(3):113-20. PubMed ID: 12112305
[TBL] [Abstract][Full Text] [Related]
12. Selenium compounds inhibit I kappa B kinase (IKK) and nuclear factor-kappa B (NF-kappa B) in prostate cancer cells.
Gasparian AV; Yao YJ; Lü J; Yemelyanov AY; Lyakh LA; Slaga TJ; Budunova IV
Mol Cancer Ther; 2002 Oct; 1(12):1079-87. PubMed ID: 12481431
[TBL] [Abstract][Full Text] [Related]
13. Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells.
Hu H; Jiang C; Ip C; Rustum YM; Lü J
Clin Cancer Res; 2005 Mar; 11(6):2379-88. PubMed ID: 15788689
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers.
Dong Y; Zhang H; Gao AC; Marshall JR; Ip C
Mol Cancer Ther; 2005 Jul; 4(7):1047-55. PubMed ID: 16020662
[TBL] [Abstract][Full Text] [Related]
15. A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.
Ben Jemaa A; Sallami S; Céraline J; Oueslati R
Cell Biol Int; 2013 May; 37(5):464-70. PubMed ID: 23418075
[TBL] [Abstract][Full Text] [Related]
16. Persistent p21Cip1 induction mediates G(1) cell cycle arrest by methylseleninic acid in DU145 prostate cancer cells.
Wang Z; Lee HJ; Chai Y; Hu H; Wang L; Zhang Y; Jiang C; Lü J
Curr Cancer Drug Targets; 2010 May; 10(3):307-18. PubMed ID: 20370687
[TBL] [Abstract][Full Text] [Related]
17. Selenite treatment inhibits LAPC-4 tumor growth and prostate-specific antigen secretion in a xenograft model of human prostate cancer.
Bhattacharyya RS; Husbeck B; Feldman D; Knox SJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):935-40. PubMed ID: 18760546
[TBL] [Abstract][Full Text] [Related]
18. Effects of naturally occurring and synthetic organoselenium compounds on protein profiling in androgen responsive and androgen independent human prostate cancer cells.
Sinha R; Pinto JT; Facompre N; Kilheffer J; Baatz JE; El-Bayoumy K
Nutr Cancer; 2008; 60(2):267-75. PubMed ID: 18444160
[TBL] [Abstract][Full Text] [Related]
19. Augmented suppression of androgen receptor signaling by a combination of alpha-tocopheryl succinate and methylseleninic acid.
Zhang H; Wu Y; Malewicz B; Lu J; Li S; Marshall J; Ip C; Dong Y
Cancer; 2006 Dec; 107(12):2942-8. PubMed ID: 17120196
[TBL] [Abstract][Full Text] [Related]
20. Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells.
Jiang C; Wang Z; Ganther H; Lu J
Cancer Res; 2001 Apr; 61(7):3062-70. PubMed ID: 11306488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
